| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5730VNW22X |
| InChI Key | GBEUKTWTUSPHEE-PAWGCEJPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H34FN5O2 |
| Molecular Weight | 479.6 |
| AlogP | 4.13 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 90.98 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 35.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | Androgen Receptor modulator |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 14.77 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -0.8--0.34 | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
0.65-144 | 6.6-196 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sarcopenia | 2 | D055948 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545333 |
| FDA SRS | 5730VNW22X |
| PubChem | 11950726 |
| SureChEMBL | SCHEMBL13604131 |